Skip to main content

Clinical Trials › NCT06587828

Recruiting

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Sponsored by TScan Therapeutics, Inc.

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
300
Target enrollment
9
U.S. states
Jan 2023
Start date
Jan 2027
Expected completion

Interventions / Treatments

Companion blood samples with procedure

Conditions studied

Multiple Sclerosis

Where this trial is running (12 sites)

Cranston · Cranston · Cranston
California2 sites
Orange · Sherman Oaks
Illinois1 site
Skokie
Kentucky1 site
Lexington
Waltham
Harrisburg
Summerville
Texas1 site
Bellaire
Wisconsin1 site
Milwaukee

Participating MS centers on MS Buddy (2)

MS centers in Rhode Island

Compare treatment centers near a trial site by center type, providers and trials.

View Rhode Island centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play